New Zealand's Pharmac says a new multiproduct agreement with Roche is delivering benefits for patients and the health system, reducing treatment times and freeing up thousands of infusion hours across hospitals.
Pharmac says new agreement has improved access to treatment for New Zealanders
March 10, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
Alterity Therapeutics updates investors on key meeting with US regulator
March 30, 2026 - - Australian Biotech -
Aroa Biosurgery reports promising trial milestone for advanced wound treatment
March 30, 2026 - - Australian Biotech -
Genetic Signatures reshapes its business to cut costs and drive growth
March 30, 2026 - -
Cynata reaches crucial milestone as Phase 2 trial moves toward results
March 30, 2026 - - Australian Biotech -
AI meets oncology as Algorae advances drug discovery collaboration
March 30, 2026 - - Australian Biotech -
The minister was subtle, but read between the lines, and the message could hardly be clearer
March 30, 2026 - - Latest News -
Government expands access to cancer therapy but holds short on pan-tumour listing
March 30, 2026 - - Latest News
